BACKGROUND: In men, high adiponectin concentrations were related to a lower risk of myocardial infarction, whereas no association with cardiovascular events was found in women. OBJECTIVE: To investigate sex differences in the associations of adiponectin with cardiovascular risk factors. DESIGN: Cross-sectional population-based KORA Survey 2000 in Southern Germany using the same study methods for cardiovascular risk factors as the former WHO MONICA project. PARTICIPANTS: A total of 697 men and 657 women, aged 55-74 years. Glucose tolerance status was assessed by oral glucose tolerance tests. RESULTS: Adiponectin (geometric mean, interquartile range; microg/ml) levels were significantly higher in women (11.1; 8.5-14.9) than in men (7.1; 5.2-9.6) (P<0.05). In univariate analyses, HDL-cholesterol and age were significantly positively correlated with adiponectin in both sexes. Negative correlations were observed with BMI, waist circumference, fasting and postchallenge glucose, insulin, HOMA-IR, HbA1c, triglycerides, uric acid and CRP (P<0.01). In sex-specific multivariate regression, age and HDL-cholesterol were independently positively, and fasting insulin and 2-h glucose were negatively related to adiponectin in both sexes. Uric acid was significantly inversely related to adiponectin in women only (sex interaction: P=0.02). Exploratory sex-specific factor analysis of adiponectin and the core components of the metabolic syndrome yielded four similar factors. Adiponectin loaded negatively on the 'lipids' factor in both sexes. CONCLUSION: The associations of adiponectin with cardiovascular risk factors showed a similar pattern in both sexes, except for uric acid. This small sex difference may not explain previous conflicting results on the association of adiponectin with cardiovascular events in men and women.
BACKGROUND: In men, high adiponectin concentrations were related to a lower risk of myocardial infarction, whereas no association with cardiovascular events was found in women. OBJECTIVE: To investigate sex differences in the associations of adiponectin with cardiovascular risk factors. DESIGN: Cross-sectional population-based KORA Survey 2000 in Southern Germany using the same study methods for cardiovascular risk factors as the former WHO MONICA project. PARTICIPANTS: A total of 697 men and 657 women, aged 55-74 years. Glucose tolerance status was assessed by oral glucose tolerance tests. RESULTS:Adiponectin (geometric mean, interquartile range; microg/ml) levels were significantly higher in women (11.1; 8.5-14.9) than in men (7.1; 5.2-9.6) (P<0.05). In univariate analyses, HDL-cholesterol and age were significantly positively correlated with adiponectin in both sexes. Negative correlations were observed with BMI, waist circumference, fasting and postchallenge glucose, insulin, HOMA-IR, HbA1c, triglycerides, uric acid and CRP (P<0.01). In sex-specific multivariate regression, age and HDL-cholesterol were independently positively, and fasting insulin and 2-h glucose were negatively related to adiponectin in both sexes. Uric acid was significantly inversely related to adiponectin in women only (sex interaction: P=0.02). Exploratory sex-specific factor analysis of adiponectin and the core components of the metabolic syndrome yielded four similar factors. Adiponectin loaded negatively on the 'lipids' factor in both sexes. CONCLUSION: The associations of adiponectin with cardiovascular risk factors showed a similar pattern in both sexes, except for uric acid. This small sex difference may not explain previous conflicting results on the association of adiponectin with cardiovascular events in men and women.
Authors: Hadeel Alkofide; Gordon S Huggins; Robin Ruthazer; Joni R Beshansky; Harry P Selker Journal: Diab Vasc Dis Res Date: 2015-07-20 Impact factor: 3.291
Authors: Mary H Zhang; Christian Spies; Sadia Ali; Alka M Kanaya; Nelson B Schiller; Mary A Whooley Journal: Atherosclerosis Date: 2008-11-25 Impact factor: 5.162
Authors: Aurelian Bidulescu; Jiankang Liu; Zhimin Chen; Demarc A Hickson; Solomon K Musani; Tandaw E Samdarshi; Ervin R Fox; Herman A Taylor; Gary H Gibbons Journal: Front Public Health Date: 2013-05-24
Authors: Qiaoxuan Wang; Jinhua Yin; Lu Xu; Hong Cheng; Xiaoyuan Zhao; Hongding Xiang; Hugh Simon Lam; Jie Mi; Ming Li Journal: BMC Public Health Date: 2013-03-21 Impact factor: 3.295
Authors: Helmut Laumen; Akuma D Saningong; Iris M Heid; Jochen Hess; Christian Herder; Melina Claussnitzer; Jens Baumert; Claudia Lamina; Wolfgang Rathmann; Eva-Maria Sedlmeier; Norman Klopp; Barbara Thorand; H-Erich Wichmann; Thomas Illig; Hans Hauner Journal: Diabetes Date: 2008-12-15 Impact factor: 9.461